Author

Ricardo Santana

Institution: Moffitt Cancer Center

Observed institution: Moffitt Cancer Center

OpenAlex ID: A5091379679

Phase II Study of Lenalidomide in Combination with Rituximab for Patients with CD5+/CD20+ Hematologic Malignancies Who Relapse or Progress After Rituximab. Interim Analysis.

2009 · Marays Veliz, Ricardo Santana, et al. · Blood · 7

Hypercalcemia Following Treatment with Lenalidomide in Chronic Lymphocytic Leukemia (CLL).

2009 · Bijal D. Shah, Marays Veliz, et al. · Blood

Works count: 2

Citation count: 7

H-index: 1

I10-index: